The US House voted to repeal and replace the Affordable Care Act on May 4.  The bill leaves the ACA’s 340B drug discount program intact.  The Senate will now review and revise the proposed House bill.  The passage of the bill is less certain in the Senate.
Representative Chris Collins (R- N.Y.) recently has made a commitment from the Energy & Commerce Health subcommittee to consider a bill that will draw a clear “line in the sand” for a qualified patient definition. More information about legislation changes to 340B will be addressed at our conference on May 31st in North Platte or June 1st in Lincoln.   Links to register are below:
To sign up for the conference in North Platte follow this link:
To sign up for the conference in Lincoln Follow this link:

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our team.

You have Successfully Subscribed!